المؤلفون: Овсянникова, Е., Накстхоева, Э., Заклякова, Л., Левитан, Б.

مصطلحات موضوعية: ХРОНИЧЕСКИЙ МИЕЛОЛЕЙКОЗ,ГЛИВЕК (ИМАТИНИБ),SFAS-L,CHRONIC MYELOID LEUKEMIA,GLIVEC (IMATINIB),APOP-TOSIS INDUCTOR SFAS-L

الوصف: Статья посвящена проблемам лечения хронического миелолейкоза, связанным с малочувствительностью к гливекозу у некоторой части больных, что определяет необходимость поиска дополнительных маркеров прогноза. В качестве такого маркера предлагается использовать индуктор апоптоза sFAS-L. ; The article considers the problems of chronic myeloid leukemia connected with some patients' little sensitivity to glivec, which determines the necessity of searching for additional markers of prognosis. Therefore apoptosis inductor sFAS-Lis offered as such a marker.

وصف الملف: text/html

الإتاحة: http://cyberleninka.ru/article/n/ispolzovanie-induktora-apoptoza-sfas-l-dlya-kontrolya-za-terapiey-i-ishodami-hronicheskogo-mieloleykozaTest
http://cyberleninka.ru/article_covers/14203827.pngTest

المؤلفون: 徐碧荷, 薛昀, 陈晓芹, 肖蓉心, 李彬, 隋锡朝, 丁玲昱, 焦运燊, 阴凯麟, 李欢欢, 高子蕊, 陈曦, 郭丽凯, 王倩倩, 冯金秋, 王月丹, 初明

المساهمون: 北京大学医学部基础医学院，北京 100191, 卫生部医学免疫学重点实验室，北京 100191, 卫生部医学免疫学重点实验室,北京,100191, 重庆涪陵中心医院,重庆,408000, 首都医科大学燕京医学院,北京,101300

المصدر: 知网 ; 万方 ; http://d.g.wanfangdata.com.cn/Periodical_zhyxdzzz201702001.aspxTest

مصطلحات موضوعية: 癌睾丸抗原, 乳腺癌, 靶点, 凋亡, 免疫应答, cancer-testis antigen, breast cancer, target, apop-tosis, immune response

الوصف: 癌睾丸抗原（ CTA）是一类特异性较高的肿瘤抗原，只在多种恶性肿瘤和睾丸表达。 CTA能作为靶点，诱导吞噬性T细胞介导的CTL免疫反应，而正常含有CTA的睾丸细胞中因缺少MHCⅠ类分子而避免免疫系统的攻击。乳腺癌是女性最常见的恶性肿瘤之一，并在引起死亡的疾病中位居前列。乳腺癌中存在的CTA对乳腺癌治疗方法的发展有着重大的意义。本文围绕乳腺癌中CTA的表达， CTA的功能以及对于乳腺癌治疗的价值作此综述。 ; Cancer?testis antigen is a kind of cancer antigen with highly restricted expression. It is expressed in a wide variety of malignant tumors but it?s expression in normal tissue is mostly restricted to germ cells of the testis. CTAs can elicit immune response mediated by cytotoxic T lymphocytes, while testis cells miss the attack due to the lack of MHC class 1 molecules. Breast cancer is one of the most common and death?related diseases among women. Nevertheless, the incidence of CTAs in breast cancer brings hope to the development of breast cancer therapy. In this review, we briefly described the expression of CTAs in breast cancer, and summarized the biological function of CTAs as well as the value of applying CTAs to breast cancer immunotherapy. ; 国家自然科学基金资助项目; 北京市自然基金项目; 北京市重点学科基础医学学科建设项目; 北京市自然科学基金资助项目; 深圳市科技项目资助项目; 重庆市科委课题资助项目; 首都医科大学自然科学基金 ; 2 ; 1-4 ; 4

العلاقة: 转化医学电子杂志. 2017, 4(2), 1-4.; 1951621; http://hdl.handle.net/20.500.11897/488720Test

الإتاحة: https://doi.org/20.500.11897/488720Test
https://doi.org/10.3969/j.issn.2095-6894.2017.02.001Test
https://hdl.handle.net/20.500.11897/488720Test

المؤلفون: Yun-hua Lu, Cong Tang, Wei Wang, Tao Xi

المساهمون: The Pennsylvania State University CiteSeerX Archives

مصطلحات موضوعية: RNAi, Survivin gene, p53 gene, Apop- tosis, HepG2

الوصف: Down regulation of surviving gene and up regulation of p53 gene expression by siRNA induces apoptosis in human hepatocellular carcinoma cell line HepG2

العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.613.3579Test